Dabrafenib Plus Trametinib as Adjuvant Therapy in Japanese Patients With Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases
Melanoma Res. 2021 Sep 13;[EPub Ahead of Print], R Amagai, Y Muto, H Kato, S Matsushita, T Maekawa, S Fukushima, K Yoshino, H Uchi, Y Fujisawa, Y Yamamoto, K Ohuchi, Y Kambayashi, T FujimuraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.